G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 1 057.2 INR 2.9% Market Closed
Market Cap: 129.5B INR
Have any thoughts about
Glenmark Life Sciences Ltd?
Write Note

Glenmark Life Sciences Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Glenmark Life Sciences Ltd
Accrued Liabilities Peer Comparison

Comparables:
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
M
MANKIND

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Life Sciences Ltd
NSE:GLS
Accrued Liabilities
â‚ą550.9m
CAGR 3-Years
39%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Accrued Liabilities
â‚ą12.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Glenmark Life Sciences Ltd's Accrued Liabilities?
Accrued Liabilities
550.9m INR

Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Accrued Liabilities amounts to 550.9m INR.

What is Glenmark Life Sciences Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
42%

Over the last year, the Accrued Liabilities growth was 0%. The average annual Accrued Liabilities growth rates for Glenmark Life Sciences Ltd have been 39% over the past three years , 42% over the past five years .

Back to Top